Ruijin Hospital — Shanghai, Shanghai Municipality

Public research footprint of Ruijin Hospital, compiled from the ClinicalTrials.gov public registry.

1,307

Registered studies

545

Active

335

Recruiting now

359

Completed

Stopped or withdrawn

Most-studied conditions

Colitis, Ulcerative · Diffuse Large B-Cell Lymphoma (DLBCL) · Parkinson's Disease (PD) · Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer

Recently updated registry entries

NCT07317934 — Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related… (Recruiting)
NCT07355296 — PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With… (Recruiting)
NCT07174310 — A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Ruijin Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.